
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602,... ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1 | -26.8817204301 | 3.72 | 3.7543 | 2.67 | 1054414 | 3.09882314 | CS |
4 | 0.27 | 11.0204081633 | 2.45 | 3.97 | 2.25 | 934148 | 3.27422591 | CS |
12 | 1.29 | 90.2097902098 | 1.43 | 3.97 | 1.05 | 600961 | 2.43091761 | CS |
26 | 0.74 | 37.3737373737 | 1.98 | 3.97 | 1.05 | 533243 | 2.11760536 | CS |
52 | 0.05 | 1.87265917603 | 2.67 | 4.13 | 1.05 | 582889 | 2.52106553 | CS |
156 | -3.92 | -59.0361445783 | 6.64 | 10.88 | 0.359908 | 566812 | 2.99881735 | CS |
260 | -39.78 | -93.6 | 42.5 | 56.5899 | 0.359908 | 432931 | 7.89461606 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.